Diabetes Care, Vol 21, Issue 12 2129-2134, Copyright © 1998 by American Diabetes Association
Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data
RL Chaiken, M Eckert-Norton, M Bard, MA Banerji, J Palmisano, I Sachimechi and HE Lebovitz
Division of Endocrinology and Metabolism, State University of New York-Health Science Center at Brooklyn 11203, USA.
OBJECTIVE: Hyperfiltration may play a role in the development of diabetic
nephropathy. African-American patients with diabetes have more than a
fourfold increase in end-stage renal disease. The purpose of this study is
to evaluate the impact of hyperfiltration on renal function in
African-American patients with type 2 diabetes. RESEARCH DESIGN AND
METHODS: Renal function of 194 African-American patients with diagnosed
type 2 diabetes from 1 month to 36 years was assessed by studies of
isotopic glomerular filtration rate (GFR), serum creatinine, creatinine
clearance, and 24-h urinary albumin excretion rates. Thirty-four patients
with a duration of diagnosed type 2 diabetes from 1 month to 10 years were
found to have hyperfiltration (GFR > or = 140 ml.min-1.1.73 m-2).
Fifteen of these patients received longitudinal follow-up of renal function
for as long as 15 years after the initial study. RESULTS: Hyperfiltration
is present in 15 (36%) of 42 patients whose duration of diagnosed type 2
diabetes is < 1 year, and it persists for up to 10 years in 14-20% of
patients with diagnosed type 2 diabetes. Patients with hyperfiltration are
younger than their counterparts without hyperfiltration when matched for
duration of diagnosed diabetes. When followed over time, those patients
with hyperfiltration were not more likely to develop impaired renal
function as measured by GFR or creatinine clearance. CONCLUSIONS:
Hyperfiltration does not identify patients at risk for deterioration in
renal function.